Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
Go back to Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 58.41 -0.52 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.93 | 52 Week High | $3.48 | |||
| Open | $58.63 | 52 Week Low | $0.80 | |||
| Day High | $58.96 | P/E | N/A | |||
| Day Low | $57.97 | EPS | $-1.54 | |||
| Volume | 7,104,686 | |||||
